Pharmacological evidence for involvement of phospholipase D, protein kinase C, and sodium-calcium exchanger in alpha-adrenoceptor-mediated negative inotropy in adult mouse ventricle

J Pharmacol Sci. 2003 Jul;92(3):196-202. doi: 10.1254/jphs.92.196.

Abstract

The intracellular signalling pathway for alpha-adrenoceptor-mediated negative inotropy was studied pharmacologically in isolated adult mouse ventricle. The negative inotropy was inhibited by GF-109203X, a nonselective protein kinase C inhibitor. Phorbol 12-myristate 13-acetate also produced sustained negative inotropy, which was inhibited by KB-R7943, a Na(+)/Ca(2+) exchanger inhibitor. The alpha-adrenoceptor-mediated negative inotropy was augmented by RHC-80267, a diacylglycerol lipase inhibitor, but was inhibited either by C(2)-ceramide, a phospholipase D inhibitor, and high concentration of propranolol (50 micro M), which inhibits phosphatidate phosphohydrolase. The inotropy was not affected by U-73122, a phospholipase C inhibitor. Lavendustin-A, a tyrosine kinase inhibitor, also inhibited the negative inotropy. These findings suggest that alpha-adrenoceptor-mediated negative inotropy in adult mouse ventricle is mediated by activation of tyrosine kinase, the phospholipase D-phosphatidate phosphohydrolase pathway, and protein kinase C.

MeSH terms

  • Animals
  • Depression, Chemical
  • Enzyme Inhibitors / pharmacology
  • In Vitro Techniques
  • Mice
  • Myocardial Contraction / drug effects*
  • Myocardial Contraction / physiology
  • Phospholipase D / antagonists & inhibitors
  • Phospholipase D / metabolism*
  • Protein Kinase C / antagonists & inhibitors
  • Protein Kinase C / metabolism*
  • Receptors, Adrenergic, alpha / metabolism*
  • Sodium-Calcium Exchanger / agonists
  • Sodium-Calcium Exchanger / metabolism*
  • Ventricular Function, Right / drug effects
  • Ventricular Function, Right / physiology

Substances

  • Enzyme Inhibitors
  • Receptors, Adrenergic, alpha
  • Sodium-Calcium Exchanger
  • Protein Kinase C
  • Phospholipase D